4//SEC Filing
Gao Hanlin 4
Accession 0000950170-25-060278
CIK 0001674930other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 4:54 PM ET
Size
5.0 KB
Accession
0000950170-25-060278
Insider Transaction Report
Form 4
Gao Hanlin
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-04-26$18.88/sh−1,157$21,844→ 963,153 total
Footnotes (1)
- [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001684532
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 4:54 PM ET
- Size
- 5.0 KB